UGT1A1 and metabolic dysfunction-associated steatotic liver disease: No significant difference of circulating UGT1A1 levels were observed between NAFLD patients and controls, but the circulating UGT1A1 levels were positively correlated with liver fat fraction in patients with severe steatosis.